Search research articles
Contact Us
Filters
Showing results (161-170 of 187) with videos related to
Page
of 19
Sort By:
Arquivos Brasileiros De Cardiologia
|
September 29, 2011
[I Latin American guidelines for the diagnosis and treatment of Chagas cardiomyopathy]
Jadelson Pinheiro de Andrade, José Antônio Marin-Neto, Angelo Amato Vincenzo de Paola, et al.
Arquivos Brasileiros De Cardiologia
|
July 27, 2011
I Latin American Guidelines for the diagnosis and treatment of Chagas' heart disease: executive summary
Jadelson Pinheiro de Andrade, Jose Antonio Marin Neto, Angelo Amato Vincenzo de Paola, et al.
JACC. Heart Failure
|
August 7, 2024
Sacubitril/Valsartan Versus Enalapril in Chronic Chagas Cardiomyopathy: Rationale and Design of the PARACHUTE-HF Trial
Edimar Alcides Bocchi, Luis E Echeverria, Caroline Demacq, et al.
Trials
|
April 18, 2020
Hypotheses, rationale, design, and methods for prognostic evaluation of a randomized comparison between patients with coronary artery disease associated with ischemic cardiomyopathy who undergo medical or surgical treatment: MASS-VI (HF)
Paulo Cury Rezende, Whady Hueb, Edimar Alcides Bocchi, et al.
Plos Neglected Tropical Diseases
|
November 15, 2012
Myocardial chemokine expression and intensity of myocarditis in Chagas cardiomyopathy are controlled by polymorphisms in CXCL9 and CXCL10
Luciana Gabriel Nogueira, Ronaldo Honorato Barros Santos, Barbara Maria Ianni, et al.
European Heart Journal. Cardiovascular Imaging
|
April 6, 2017
Decreased glycolytic metabolism in non-compaction cardiomyopathy by 18F-fluoro-2-deoxyglucose positron emission tomography: new insights into pathophysiological mechanisms and clinical implications
Marcelo Dantas Tavares de Melo, Maria Clementina Pinto Giorgi, Antonildes Nascimento Assuncao, et al.
Circulation
|
November 13, 2025
Sacubitril-Valsartan for the Prevention of Anthracycline Cardiotoxicity in Patients With Elevated Cardiac Troponin I Concentration During Chemotherapy: A Double-Blind Randomized Placebo-Controlled Clinical Trial: The SARAH Trial
Marcely Gimenes Bonatto, Mônica Samuel Avila, Sílvia Moreira Ayub Ferreira, et al.
JHLT Open
|
March 27, 2025
Development of a hub-and-spoke durable left ventricular assist device program in Brazil, a middle-income country
Deborah de Sá Pereira Belfort, Bruno Biselli, Mônica Samuel Avila, et al.
Memorias Do Instituto Oswaldo Cruz
|
November 16, 2022
Genetic diversity of Trypanosoma cruzi strains isolated from chronic chagasic patients and non-human hosts in the state of São Paulo, Brazil
Thiago Kury Moreno de Souza, Elizabeth Visone Nunes Westphalen, Sansão da Rocha Westphalen, et al.
JHLT Open
|
March 27, 2025
Corrigendum to "Development of a hub-and-spoke durable left ventricular assist device program in Brazil, a middle-income country" [JHLT Open, 6 (2024) 100151]
Deborah de Sá Pereira Belfort, Bruno Biselli, Mônica Samuel Avila, et al.
Page
of 19
Search research articles
Search
Showing results (161-170 of 187) with videos related to
Sort By:
Page
of 19
Arquivos Brasileiros De Cardiologia
|
September 29, 2011
[I Latin American guidelines for the diagnosis and treatment of Chagas cardiomyopathy]
Jadelson Pinheiro de Andrade, José Antônio Marin-Neto, Angelo Amato Vincenzo de Paola, et al.
Arquivos Brasileiros De Cardiologia
|
July 27, 2011
I Latin American Guidelines for the diagnosis and treatment of Chagas' heart disease: executive summary
Jadelson Pinheiro de Andrade, Jose Antonio Marin Neto, Angelo Amato Vincenzo de Paola, et al.
JACC. Heart Failure
|
August 7, 2024
Sacubitril/Valsartan Versus Enalapril in Chronic Chagas Cardiomyopathy: Rationale and Design of the PARACHUTE-HF Trial
Edimar Alcides Bocchi, Luis E Echeverria, Caroline Demacq, et al.
Trials
|
April 18, 2020
Hypotheses, rationale, design, and methods for prognostic evaluation of a randomized comparison between patients with coronary artery disease associated with ischemic cardiomyopathy who undergo medical or surgical treatment: MASS-VI (HF)
Paulo Cury Rezende, Whady Hueb, Edimar Alcides Bocchi, et al.
Plos Neglected Tropical Diseases
|
November 15, 2012
Myocardial chemokine expression and intensity of myocarditis in Chagas cardiomyopathy are controlled by polymorphisms in CXCL9 and CXCL10
Luciana Gabriel Nogueira, Ronaldo Honorato Barros Santos, Barbara Maria Ianni, et al.
European Heart Journal. Cardiovascular Imaging
|
April 6, 2017
Decreased glycolytic metabolism in non-compaction cardiomyopathy by 18F-fluoro-2-deoxyglucose positron emission tomography: new insights into pathophysiological mechanisms and clinical implications
Marcelo Dantas Tavares de Melo, Maria Clementina Pinto Giorgi, Antonildes Nascimento Assuncao, et al.
Circulation
|
November 13, 2025
Sacubitril-Valsartan for the Prevention of Anthracycline Cardiotoxicity in Patients With Elevated Cardiac Troponin I Concentration During Chemotherapy: A Double-Blind Randomized Placebo-Controlled Clinical Trial: The SARAH Trial
Marcely Gimenes Bonatto, Mônica Samuel Avila, Sílvia Moreira Ayub Ferreira, et al.
JHLT Open
|
March 27, 2025
Development of a hub-and-spoke durable left ventricular assist device program in Brazil, a middle-income country
Deborah de Sá Pereira Belfort, Bruno Biselli, Mônica Samuel Avila, et al.
Memorias Do Instituto Oswaldo Cruz
|
November 16, 2022
Genetic diversity of Trypanosoma cruzi strains isolated from chronic chagasic patients and non-human hosts in the state of São Paulo, Brazil
Thiago Kury Moreno de Souza, Elizabeth Visone Nunes Westphalen, Sansão da Rocha Westphalen, et al.
JHLT Open
|
March 27, 2025
Corrigendum to "Development of a hub-and-spoke durable left ventricular assist device program in Brazil, a middle-income country" [JHLT Open, 6 (2024) 100151]
Deborah de Sá Pereira Belfort, Bruno Biselli, Mônica Samuel Avila, et al.
Page
of 19